Your fact-checks will appear here
The manufacturing and regulation of pharmaceutical-grade ivermectin for human use, emphasizing strict purity and defined dosages.
for humans is explicitly weight‑based: recommended therapeutic regimens are expressed in micrograms or milligrams per kilogram of body weight rather than by a fixed tablet count . A single 12 mg dose ...
as an anticancer agent is nascent: small, early-phase combination trials have used oral, pulsed schedules (for example, days 1–3, 8–10, 15–17 of a 21‑day cycle) alongside immune checkpoint inhibitors,...
High‑dose or prolonged ivermectin use has most often produced mild, transient symptoms—headache, dizziness, nausea, rash and gastrointestinal upset—across clinical studies, but rare serious events inc...